Suppr超能文献

对于儿童阑尾穿孔手术后,推荐使用阿莫西林/克拉维酸的短疗程抗生素治疗。

A shortened course of Amoxicillin/Clavulanate is the preferred antibiotic treatment after surgery for perforated appendicitis in children.

机构信息

Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, 1653 West Congress Parkway, Kellogg 7, Chicago, IL 60612, United States.

Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, 1653 West Congress Parkway, Kellogg 7, Chicago, IL 60612, United States.

出版信息

J Pediatr Surg. 2023 Mar;58(3):558-563. doi: 10.1016/j.jpedsurg.2022.03.032. Epub 2022 Apr 5.

Abstract

BACKGROUND/PURPOSE: Despite evidence supporting short course outpatient antibiotic treatment following appendectomy for perforated appendicitis, evidence of real-world implementation and consensus for antibiotic choice is lacking. We therefore aimed to compare outpatient antibiotic treatment regimens in a national cohort.

METHODS

We identified children who underwent surgery for perforated appendicitis between 2010 and 2018 using the PearlDiver database and compared 45-day disease-specific readmission between children who received shortened (5-8 days) versus prolonged (10-14 day) total antibiotic courses (inpatient intravenous and/or oral) completed with outpatient Amoxicillin/Clavulanate versus Ciprofloxacin/Metronidazole, and compared antibiotic type (5-14 days) to each other.

RESULTS

4916 children were identified, 2001 (90.0%) treated with Amoxicillin/Clavulanate (5-14 days), 381 (19.0%) with shortened (5-8 days), 1464 (73.2%) with prolonged (10-14 days) courses. 222 (10.0%) were treated with Ciprofloxacin/Metronidazole, 44 (19.8%) with shortened, 174 (78.4%) with prolonged courses. Freedom from readmission was not different between prolonged and shortened course whether they received Amoxicillin/Clavulanate (adjusted hazard ratio [AHR] 1.54, 95%CI 0.95-2.5) or Ciprofloxacin/Metronidazole (AHR 3.49, 95%CI 0.45-27.3). Antibiotic type did not affect readmission rate (Amoxicillin/Clavulanate versus Ciprofloxacin/Metronidazole, AHR 1.21, 95%CI 0.71-2.05).

CONCLUSION

Prolonged antibiotic regimens are routinely prescribed despite evidence suggesting shorter courses and antibiotic choice are not associated with greater treatment failure. As it is better tolerated, we recommend a shortened course of Amoxicillin/Clavulanate for oral management of perforated appendicitis.

STUDY DESIGN

Retrospective.

LEVEL OF EVIDENCE

Level III.

摘要

背景/目的:尽管有证据支持穿孔性阑尾炎阑尾切除术后短期门诊抗生素治疗,但缺乏真实世界实施和抗生素选择共识的证据。因此,我们旨在比较全国队列中的门诊抗生素治疗方案。

方法

我们使用 PearlDiver 数据库确定了 2010 年至 2018 年间接受手术治疗的穿孔性阑尾炎患儿,并比较了接受缩短(5-8 天)与延长(10-14 天)总抗生素疗程(住院静脉和/或口服)的患儿 45 天疾病特异性再入院率,这些患儿使用门诊阿莫西林/克拉维酸钾与环丙沙星/甲硝唑完成治疗,比较了抗生素类型(5-14 天)之间的差异。

结果

共确定了 4916 名患儿,2001 名(90.0%)接受阿莫西林/克拉维酸钾(5-14 天)治疗,381 名(19.0%)接受缩短(5-8 天)治疗,1464 名(73.2%)接受延长(10-14 天)治疗。222 名(10.0%)接受环丙沙星/甲硝唑治疗,44 名(19.8%)接受缩短治疗,174 名(78.4%)接受延长治疗。无论接受阿莫西林/克拉维酸钾(调整后的危险比 [AHR] 1.54,95%CI 0.95-2.5)还是环丙沙星/甲硝唑(AHR 3.49,95%CI 0.45-27.3)治疗,延长疗程与缩短疗程的再入院率无差异。抗生素类型不影响再入院率(阿莫西林/克拉维酸钾与环丙沙星/甲硝唑,AHR 1.21,95%CI 0.71-2.05)。

结论

尽管有证据表明较短疗程,但仍常规使用延长抗生素治疗方案,且抗生素选择与更高的治疗失败率无关。由于其耐受性更好,我们建议使用缩短疗程的阿莫西林/克拉维酸钾口服治疗穿孔性阑尾炎。

研究设计

回顾性。

证据水平

III 级。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验